Skip to content
Open access

Thrombin reshapes α-synuclein biochemical properties by N-terminal truncation

Oct 2026 · Nature Communications · 0 citations

TL;DR

It is shown that thrombin, a serine protease associated with inflammatory conditions, selectively cleaves α-Synuclein at Lys6–Gly7, generating a 7–140 fragment despite the presence of multiple potential cleavage sites.

Abstract

Proteolytic processing of α-Synuclein (Syn) contributes to the molecular diversity and toxicity of its aggregates in Parkinson’s disease, yet the proteases responsible for disease-relevant truncations remain incompletely defined. Here, we show that thrombin, a serine protease associated with inflammatory conditions, selectively cleaves Syn at Lys6–Gly7, generating a 7–140 fragment despite the presence of multiple potential cleavage sites. Cleavage is modulated by ionic strength and the conformational ensemble of Syn, with more extended states being preferentially cleaved. The resulting 7–140 fragment adopts a more compact conformational ensemble, delays the formation of aggregation-prone species, produces fibrils with altered morphology and shows reduced membrane-induced α-helix formation. Although 7–140 aggregates are modestly less toxic, the truncation also impairs physiological functions of the protein. These findings describe a mechanism by which an inflammation-associated protease, thrombin, may contribute to Parkinson’s disease by selectively modifying Syn structure, aggregation and function.

Read PDF

Similar papers

Review Open access Nov 2026

Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis

Insight from recent DMS studies of α-synuclein are highlighted, which have implicated membrane binding as an important contribution to its toxicity and aggregation, and experiments in different cell types reveal distinct determinants of aggregation.

Daeun Noh, Robert W. Newberry · 0 citations
Open access Oct 2026

Hsp10 Targets the C-Terminus of α-Synuclein to Inhibit Secondary Nucleation and Remodel Labile Fibrils

Aggregation of α-synuclein is a central pathological feature of Parkinson’s disease and related synucleinopathies. The co-chaperonin Hsp10, a component of the Hsp60/Hsp10 chaperonin system, has recently been proposed to possess independent chaperone activity and has been found to co-localize with α-synuclein aggregates...

Muhammed Shafeek Oliyantakath Hassan, S. Call, Ayobami T. Adegbenro et al. · 0 citations
Open access Sep 2026

Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation

Heterotypic interactions with Aβ42 reshape α-syn aggregation pathways and fibril conformations, generating structurally distinct α-syn fibril populations with different neuronal seeding activities, which provide a molecular framework for understanding how cross-talk between amyloidogenic proteins may contribute to stru...

Purnopama Saha, Teshani Liyanaarachchige, Anika Alim et al. · 0 citations
Open access Oct 2026

Oxidized EGCG redirects α-synuclein aggregation through shear-selected interactions

α-Synuclein (αSyn) aggregation is central to Parkinson’s disease pathology, and the green-tea polyphenol epigallocatechin gallate (EGCG) has been studied as an inhibitor of fibril formation. However, EGCG autoxidation and analyses under static, non-fibrillating conditions have obscured whether activity arises from EGCG...

Cho-Ming Yuen, Reiji Yamaguchi, Keita Uchida et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.